Among the well-recognized estrogen-sensitive ER(+) human breast cancer cells (T-47D, MCF-7 and ZR-75-1), we selected the T-47D cell line, since it expresses a very low level of aromatase and a high level of 17β-HSD1 [58]. This evidence concerns the gene CYP19A1 and breast carcinoma.